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Abstract 23 
Atypical Aeromonas salmonicida (aAs) is currently one of the most routinely recovered 24 
bacterial pathogens isolated during disease outbreaks in farmed cleaner fish, ballan wrasse 25 
(Labrus bergylta, Ascanius). Vibrionaceae family bacteria have also been isolated from ballan 26 
wrasse in Scotland. This study determined the infectivity, pathogenicity and virulence of aAs 27 
and Vibrionaceae isolates in juvenile farmed ballan wrasse (n= 50; approx. 2 gr) using a bath 28 
challenge and fish were monitored for a period of 16 days. Atypical As caused significant 29 
mortalities in contrast to Vibrionaceae isolates. Notably, differential virulence was observed 30 
between two aAs vapA type V strains at similar challenge doses. Diseased fish exhibited a 31 
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systemic infection where aAs was detected in all analysed tissues (liver, spleen and kidney) 32 
by PCR and qPCR. Macroscopically, moribund and survivor fish exhibited hepatomegaly and 33 
splenomegaly. In moribund and surviving fish histopathology showed granulomatous hepatitis 34 
with eosinophilic granular cells surrounding bacterial colonies and endocarditis along with 35 
splenic histiocytosis. This is the first report of a successful aAs bath challenge model for 36 
juvenile ballan wrasse which provides an important tool for future studies on vaccine efficacy 37 
and immunocompetence.  38 
Keywords: atypical Aeromonas salmonicida, bath challenge, gross pathology, systemic 39 
disease, eosinophilic granular cells (EGCs).  40 
Introduction  41 
Among disease challenges faced by the Atlantic salmon (Salmo salar, Linnaeus) farming 42 
industry, caligid sea lice infections caused by Lepeophtheirus salmonis (Krøyer) and Caligus 43 
elongatus (Nordmann) had the most significant impacts since the 1960s (Hastein & Bergsjo, 44 
1976; Costello, 2006). Due to large global economic losses to the industry, for example £700 45 
million in 2015 alone (Brooker et al., 2018), there has been considerable investment and 46 
innovation on developing sea lice control strategies. The most effective control methods have 47 
been bath or in-feed medicated treatments but their efficacy is reduced due to resistance 48 
development in lice (Treasurer & Feledi, 2014). Alternative mechanical (hydrolicers, 49 
thermolicers, and lasers), physical (snorkel cages and lice skirts) and biological (cleaner fish) 50 
treatments have been applied in order to control sea lice (Holan et al., 2017). Biological control 51 
through the deployment of wild cleaner fish in salmon cages in Norway and Scotland has been 52 
effective and gaining popularity as an environmentally friendly pest management strategy 53 
(Treasurer, 2012; Skiftesvik et al., 2013). Commercial scale farming of ballan wrasse (Labrus 54 
bergylta, Ascanius) and lumpsucker (Cyclopterus lumpus, Linnaeus) is currently being used 55 
for this purpose. In Scotland, efforts have recently intensified on the farming of ballan wrasse 56 
as opposed to using wild caught animals. However, the bacterial pathogen atypical 57 
Aeromonas salmonicida (aAs), continues to cause high mortalities during the hatchery and 58 
post-deployment stages (Brooker et al., 2018). Depending on the host, typical (salmonids) and 59 
atypical (generally non – salmonids) strains of As infect a wide range of fresh and marine 60 
water fish species. High mortality events have been recorded in farmed species including 61 
Atlantic salmon, rainbow trout (Oncorhynchus mykiss, L.), Atlantic cod (Gadus morhua, L.), 62 
Atlantic halibut (Hippoglossus hippoglossus, L.) and turbot (Scophthalmus maximus, L.) 63 
(Austin & Austin, 2016). Atypical As strains are very heterogeneous and attempts have been 64 
made to characterise and categorise the different strain types. To date, four main subspecies 65 
have been described: A. salmonicida subsp. achromogenes (Smith, 1963; Schubert, 1967), 66 
masoucida (Kimura, 1969a, 1969b), smithia (Austin et al., 1989) and pectinolytica (Pavan et 67 
al., 2000). However, some strains cannot be assigned under any of these groups making 68 
vaccine development against aAs difficult. A variety of virulence factors have been 69 
characterised for As including the A- layer (Munro et al., 1984).The latter is an outer membrane 70 
protein of As (Udey & Fryer, 1978; Kay & Trust, 1991) which plays an important role in the 71 
infection of the host as well as providing protection for the bacterium to the host immune 72 
responses (Munn et al., 1982; Kay & Trust, 1991; Daly et al., 1996). Gulla et al. (2016a) 73 
demonstrated that As strains can be differentiated using the A – layer. Variations can be 74 
detected using a partial sequence technique in a region of the virulence array protein gene 75 
(vapA). In total, 23 A – layer types were differentiated by Gulla et al. (2019) while previously 76 
aAs type V (the most predominant in Scotland) and VI (mainly in Norway) were found to be 77 
associated with disease in ballan wrasse (Gulla et al., 2016a). Although there are no 78 
commercially available registered licensed vaccines to protect ballan wrasse against aAs, 79 
autogenous vaccines are currently used as an emergency solution in Scotland (Ramirez 80 
Paredez et al., 2020). While efficacy testing is not required for commercialising this type of 81 
vaccine, data on immune protection elicited by such vaccines is important for optimising 82 
treatment efficacy. Challenge models must therefore be developed for ballan wrasse to 83 
undertake vaccine testing and assess protective efficacy.  84 
The present study aimed to develop a bacterial bath challenge model for juvenile ballan 85 
wrasse using aAs and Vibrionaceae isolates that had been recovered from disease outbreaks 86 
in Scotland but without prior knowledge of their virulence. In addition, the infectivity, 87 
pathogenicity and virulence of these bacterial isolates was determined by simulating more 88 
natural bacterial portals of entry, as opposed to injection challenge, to provide a vaccination 89 
testing platform for the future. 90 
 91 
 92 
Materials and Methods  93 
Ethics statement  94 
Bacterial infection and vaccination procedures were performed under UK Government Home 95 
Office project licences P8E92D8B3 following approval by the Animal Welfare and Ethical 96 
Review Body (AWERB) at the Centre for Environment, Fisheries and Aquaculture Science 97 
(Cefas) and University of Stirling. Ballan wrasse were treated in accordance with the Animals 98 
(Scientific Procedures) Act 1986 Amended Regulations (SI 2012/3039).  99 
Experimental animals  100 
Juvenile ballan wrasse (n= 1200, 1 ± 0.2 g) were obtained from Otterferry Seafish (Scotland, 101 
UK) and transported to Cefas (Weymouth, UK) in January 2018. Fish were kept in four aerated 102 
aquaria (50 L) under a 20 h light: 4 h dark photoperiod, with water flows of 1.5 L / min and 103 
dissolved oxygen (DO) maintained at 8 ± 0.5 mg / L throughout the experiment. Fish were 104 
acclimated to the new environment for three weeks during which temperature was kept 105 
constant at 12 ± 1 °C. Temperature was then increased by 0.5 degree / day to reach 15 °C. 106 
The fish were fed with Otohime Fish Diet C1 & C2 (Biokyowa, Japan) for 7 h / day using auto 107 
feeders during the experiment.  108 
Fish health assessment 109 
The health status of the fish was assessed prior to transportation. Whole larvae (n= 60) were 110 
screened for pathogens including common isolated bacteria (aAs and Vibrionaceae) as well 111 
as amoebic gill disease (AGD) by histology, bacteriology and molecular techniques 112 
(Yamamoto et al., 2000; Young et al., 2008; Klindworth et al., 2013). In addition, the fish health 113 
(n= 60) was reassessed upon arrival to Cefas facilities for bacteriology (swabs from head 114 
kidney plated onto sea water agar (SWA)), histopathology (fixed in 10% neutral buffered 115 
formalin) and molecular methods  to provide further assurances of  biosecurity in accordance 116 
with the methodological approach reported by Ramirez-Paredes et al. (2020). Whole fish were 117 
also fixed in transport media (500 mL  G-MEM base,  50 mL foetal bovine serum, 5 mL 118 
antibiotic antimycotic stabilised solution, 5 mL glutamax 1, 5 mL penicillin – streptomycin 119 
solution, 0.8 mL Tris solution, 2.4 mL  sterile 7.5% sodium bicarbonate, OIE) for virology to 120 
confirm that fish were not carrying any notifiable viral diseases for further biosecurity 121 
assurance as listed in the OIE manual of diagnostic tests for aquatic animals (OIE, 2018). 122 
Whole fish samples were fixed in 10% neutral buffered formalin to confirm by histology that 123 
fish did not have any existing pathological conditions prior to challenge.  124 
Bacteria preparation  125 
The bacterial strains (n= 8) used were previously recovered from diseased ballan wrasse in 126 
hatcheries or cage sites in Scotland or Norway (mentioned where applicable) (Biering et al., 127 
2016; Papadopoulou, 2019).  The bacteria used were two strains of aAs vapA type V (TW 3 / 128 
14 and TW 4 / 14) and members of Vibrionaceae family including two strains of Vibrio 129 
anguillarum TW 260 / 16 and 12 – 50 2075 F383 – 1 (Norwegian), Aliivibrio salmonicida (TW 130 
189 / 16 and TW 322 / 16) and Photobacterium indicum (TW 181 / 16 and TW 138 / 16) (Table 131 
1). All bacteria were grown in Tryptone Soya Broth (TSB) + 1.5% NaCl at 22 °C for 24 h with 132 
continuous shaking at 150 rpm except atypical Aeromonas salmonicida isolates which were 133 
grown in TSB at 22 °C for 48 h. The bacteria were centrifuged at 2,000 x g for 10 min, bacterial 134 
pellets were washed with phosphate buffered saline (PBS) and then re – suspended in sterile 135 
sea water to an OD550 1. Colony forming unit (CFU) per mL were counted by the 10 – fold 136 
dilution method. 137 
Challenge  138 
Ballan wrasse (1.5 ± 0.3 g) were randomly selected from the holding tanks (n= 4) and split into 139 
18 small challenge aquaria (5 L, 50 fish / aquarium). Experimental bacterial infection was 140 
performed in duplicate with the exception of an aAs strain (TW 3 / 14) which was found to be 141 
less virulent than TW 4 / 14 at similar doses when previously used for an intraperitoneal (i.p.) 142 
injection trial in ballan wrasse (Ramirez Paredez et al., 2020).This strain was prepared in two 143 
doses (107 and 108 CFU/ mL) to assess changes in virulence. The study consisted of 16 144 
challenged (n= 4 bacterial species x 2 strains per species x 2 tanks each) and 2 control groups. 145 
The fish were challenged with aAs vapA type V and Vibrionaceae isolates by bath in a bacterial 146 
suspension of an OD550 1.0 while control groups were exposed to sterile sea water (Table 2). 147 
All groups were challenged for 4 h at 15 °C with aeration in static conditions. Fish were 148 
monitored at least twice per day, with increasing frequency as clinical signs of infection 149 
appeared, up to16 days post infection (dpi). Individuals displaying more than two clinical signs 150 
of disease (generic and pathogen-specific) were considered as moribund and were humanely 151 
killed with an overdose of tricaine methanesulfonate MS-222 (Sigma), followed by destruction 152 
of the brain to confirm death. Mortalities were removed from the tanks as soon as they were 153 
detected. 154 
Sampling 155 
Head kidney swabs were sampled from a representative number of moribund fish (5 156 
individuals; 10 %) from each tank and plated onto tryptone soya agar (TSA aAs isolates) or 157 
TSA + 1.5 % NaCl (Vibrionaceae) to confirm infectivity and pathogen induced mortality; 158 
individuals had only been exposed to one of the four bacteria species. Bacterial colonies were 159 
confirmed based on morphology, motility, Gram staining and agglutination test (BIONOR™). 160 
Heart, intestine, posterior kidney, liver and spleen samples from moribund fish were preserved 161 
in 10 % neutral Buffer Formalin (NBF) for histology. A total of 20 moribund fish (n= 5 x 4 aAs 162 
exposed tanks) were sampled during the trial while 5 survivor fish from each tank were 163 
sampled at termination and preserved in 100% ethanol for molecular assessment. In addition, 164 
all the survivor fish exposed to TW 3 / 14 (dose 107) were sampled (n= 19) at termination as 165 
mortalities had not reached a plateau. Samples were screened with molecular assays to 166 
determining the presence of aAs as described below.  Mid kidneys, liver and spleen tissue 167 
were also sampled from control and all the survivor fish challenged with Vibrionaceae isolates 168 
and preserved in 100 % ethanol for molecular analysis. 169 
Histology & Gram Twort stain 170 
A representative number of samples (19 moribund, 12 survivor and 6 control) that had 171 
previously been fixed in 10 % NBF were dehydrated (Thermo Shandon Citadel 2000), 172 
embedded in paraffin wax, sectioned at 5 μm (Leica RM 2135) and stained with Haematoxylin 173 
and Eosin (H&E), while slides not previously stained were dewaxed and stained with Gram 174 
Twort. Images were captured using Nikon Eclipse Ni microscope (Nikon, UK) and camera with 175 
accompanying software. 176 
DNA extraction and quality check 177 
DNA was extracted from liver, spleen, and mid kidney tissue samples (n= 179, 64 fish x 3 178 
tissues; 13 spleen samples were not included as they were either too small or not sampled) 179 
previously preserved in 100% ethanol (Fisher) using a modified salt precipitation method from 180 
(Khanam et al., 2016). The extracted DNA was re-suspended in 5 mM Tris. The concentration 181 
and purity of the samples was assessed using a NanoDrop® ND-1000 (Thermo Fisher 182 
Scientific) and samples were standardised at 50 ng / μL. The DNA integrity was validated by 183 
gel electrophoresis and samples were stored at - 20°C until use.  184 
Conventional PCRs – 16S, vapA and aAs type V specific PCR 185 
The presence of bacterial DNA in the fish tissues (liver, spleen and mid kidney) was assessed 186 
on the V3-V4 hypervariable region of the 16S rRNA gene – 16S PCR (Herlemann et al., 2011); 187 
if samples were negative no further testing was carried out as bacterial load in the samples 188 
was considered below the assay detection limit. Positive samples were then screened with a 189 
species specific PCR (vapA) for the presence of As DNA using a previously published PCR 190 
protocol targeting the hypervariable region of vapA gene – vapA PCR (Gulla et al., 2016a). 191 
The presence or absence of aAs vapA type V was then determined using a previously 192 
developed aAs vapA type V specific PCR (aAs type V specific PCR) (Papadopoulou, 2019). 193 
The primer pair used for the tissue samples screening with conventional PCRs are listed in 194 
Table 3. The relative molecular weight of the amplicons was compared against a 100 bp gene 195 
ruler (Thermo Fisher Scientific) on 1 % agarose gel and visualised as previously described.  196 
Quantitative PCR (qPCR)  197 
Aeromonas salmonicida bacterial loads were assessed on tissue samples that were confirmed 198 
positive for As with the conventional PCRs using a modified qPCR protocol targeting the vapA 199 
gene (Gulla et al., 2016b). In brief, a 10 μL reaction was set up and the master mix per sample 200 
consisted of 0.03 μM of the forward and reverse (Eurofins) primers (Table 3), 0.02 μM of 201 
beacon probe (Eurofins), 5.0 μL of Luminaris colour probe qPCR master mix (Thermo Fisher 202 
Scientific), 3.2 μL of Milli-Q water and 1.0 μL of sample or control at 100 ng/μL. Milli-Q water 203 
was used as a negative control and the positive control was aAs type V isolate DNA. The 204 
following thermal cycling conditions were run in a LightCycler® 480 Instrument II (Roche 205 
Molecular Diagnostics): 1 cycle at 95 °C for 10 min, 45 cycles at 95 °C for 15 sec, 60 °C for 206 
30 sec and 72 °C for 30 sec. The analysis was performed with LightCycler® 480 software 207 
(Roche Molecular Diagnostics). The Aeromonas salmonicida type strain (NCIMB 1102) was 208 
used for the development of the standard curve for the qPCR. The bacteria were grown on 209 
TSA at 22 °C. After 48 h an inoculum was transferred into TSB and incubated in a shaker 210 
incubator at 22 °C, 150 rpm for 48 h and then bacterial DNA was extracted as described 211 
previously. The quality and quantity of the DNA was measured with the methods mentioned 212 
and 7 serial dilutions (initial concentration of 40 ng / μL) were conducted using Qubit™ 213 
(Thermo Fisher Scientific). 214 
Statistical analyses  215 
All statistical analyses were conducted using the statistical software R (R Core Team, 2020) with 216 
the packages survival (Therneau, 2020) and survminer (Kassambara et al., 2020). Survival data 217 
were analysed using Kaplan–Meier. Differences between aAs challenges were analysed by the 218 
log-rank test, using the Bonferroni correction for multiple comparisons. 219 
Results  220 
Bath challenge  221 
The bacterial infection dosages are shown in Table 2. Control fish did not show any signs of 222 
disease and no mortalities were recorded during the trial. No notable mortalities were recorded 223 
for the duplicate groups exposed to V. anguillarum, Aliiv. salmonicida or Phot. indicum, with 224 
only 2, 1 and 0 mortalities recorded, respectively. In contrast, fish challenged with the two 225 
strains of aAs vapA type V showed cumulative mortalities of 52 and 60 % (TW 4 / 14 replicates 226 
at 2.84 x 107 CFU / mL) and 20 % and 62 % (TW 3 / 14 dose at 1.93 x 107 CFU /mL  and 2.04 227 
x 108 CFU /mL, respectively) (Table 2, Figure 1). Survival was higher for individuals challenged 228 
with TW 3 / 14 dose at 1.93 x 10^7 CFU /mL than with any other aAs challenges. The log-rank 229 
shows that the challenges statistically differed significantly at the 5% significance level 230 
(p=0.00011) and pairwise comparisons indicated that TW 3 / 14 at a dose of 1.93 x 10^7 CFU 231 
/mL is statistically significantly different from the other treatments (Table 2). Fish exhibited 232 
clinical signs at 5 and 7 days post infection (dpi), for strains TW 4 / 14 and TW 3 / 14, 233 
respectively. The first mortalities were recorded at 7 dpi for both strains at the same dose of 234 
107 CFU /mL, and 9 dpi for strain TW 3/14 at dose of 108 CFU / mL. Mortalities peaked at 13 235 
dpi for the TW 3 / 14 isolate (107 CFU /mL; one of the replicates) and 14 dpi for strains TW 3 236 
/ 14 and TW 4 / 14 at 107 and 108 CFU /mL, respectively (Figure 1). Mortality rate was faster 237 
for strain TW 4 / 14 in comparison with fish infected with strain TW 3 / 14 (similar CFU / mL). 238 
Pure cultures of aAs isolated from head kidneys of moribund fish grew on TSA within 48 h at 239 
22 °C.  240 
 241 
Gross clinical signs following bath challenge  242 
Moribund fish exhibited external clinical signs of disease including uni or bilateral exophthalmia 243 
(Figure 2 A), eroded fins with complete loss of pectoral fins, haemorrhage on dorsal fin and / 244 
or tail base (Figure 2 B), skin discoloration, swollen abdomen (ascites), petechiae on the body 245 
(Figure 2 B) and haemorrhage between the eyes (Figure 2 A). Exophthalmia and eroded fins 246 
were one of the predominant gross pathological changes reported simultaneously with 247 
lethargy, loss of buoyancy and imbalance, and loss of appetite. Internally, dark red intestines 248 
(Figure 2 C), white nodular lesions in the liver (Figure 2 D), as well as hepatomegaly and 249 
splenomegaly were also observed. The liver and spleen were the two main affected organs 250 
macroscopically.  251 
Histopathology and Gram Twort staining  252 
In total 6 out of 19 (31.5 %) liver samples from moribund fish analysed exhibited granulomas 253 
and increased eosinophilic granular cell activity (Figure 3 A – C). Moribund and survivor fish 254 
demonstrated mild scattered single cell necrosis together with mild hepatocellular dissociation, 255 
congestion and distended sinusoids (Figure 3 C). In granulomatous livers, small infiltrates of 256 
lymphocytes were apparent at the periphery of the granulomas (Figure 3 A - C). The 257 
granulomatous formations ranged from large disorganised aggregates of macrophages with 258 
eosinophilic granular cells (EGCs) surrounding bacterial colonies (early stage) to well 259 
organised, walled off, granulomas (later stage) (Figure 3 A - D). Hepatocellular degeneration 260 
was also noted surrounding early lesions (Figure 3 D). Hearts from moribund fish exhibited 261 
mild to moderate granulomatous endocarditis and some samples showed endocardial 262 
hypertrophy. Intraluminal thrombi containing bacteria were also observed within the atrium 263 
(not shown). Over 93.5 % (29 of 31) of the moribund and surviving infected fish that were 264 
sampled at the termination of the trial had some degree of peritonitis (Figure 4 C & D), 265 
characterised by an increase of EGCs infiltrating the peri-pancreatic fat cells. Control fish had 266 
no pancreatic changes (Figure 4 A & B). Spleens of moribund and survivor fish had moderately 267 
reactive ellipsoids, mild to moderate histiocytosis and splenic congestion (Figure 5 C & D), 268 
which was not evident in control fish spleens (Figure 5  A & B). Spleens from the aAs infected 269 
fish also contained a moderate infiltrate of EGCs. Interestingly, no apparent differences in 270 
kidneys from both control and infected fish were observed. EGCs were found in the renal 271 
interstitium of both groups. The intestines from the fish examined microscopically were also 272 
very similar with many goblet cells in both control and infected groups. Control fish did not 273 
present any pathology in the livers, hearts or spleens. 274 
Gram-Twort stain confirmed the presence of dark pink, Gram-negative rod bacteria forming 275 
large colonies within granulomas (Figure 6 C and D) localised in the same area of H&E stained 276 
liver sections (Figure 6 A and B).  277 
PCR  278 
16S PCR 279 
Initially 179 tissue samples (liver, spleen and kidney) from 64 fish were screened with a broad 280 
range 16S rRNA PCR for detection of bacterial DNA (Table 4). Of these samples, 103 tissues 281 
(from 59 individuals) had bacterial DNA present, specifically, 39/103 (37.9%) in the liver, 282 
23/103 (22.3%) in the spleen, and 41/103 (39.8%) in the kidney. The majority of these positive 283 
samples were subclinical individuals (33/59) that had survived the challenge trial while the rest 284 
were moribund individuals (18/59) and control fish (8/59).  285 
vapA PCR 286 
In total, 30 out of 179 (16.8 %) fish tissues (liver, spleen and kidney) screened for As species 287 
–specific PCR design based on the vapA gene of As were positive for the bacterium. From 288 
the 30 As positive organs (from 21 individuals) 13/30 (43.3 %) were detected in the liver, 7/30 289 
(23.3 %) in the spleen, and 10/30 (33.3 %) in the kidney of these fish. Ten out of the 21 fish 290 
(48.0 %) had survived the challenge trial (subclinical individuals) and 11 (52.0 %) were 291 
moribund (Table 4). All control samples tested (30) were negative. There were no differences 292 
in aAs detection between the individuals challenged with either of the two aAs vapA type V 293 
stains. All the individuals challenged with Vibrionaceae isolates were negative for presence of 294 
aAs.  295 
aAs type V-specific PCR 296 
 297 
All control samples tested (30) were negative for aAs type V. In total, 29 out of 64 fish had the 298 
expected PCR product for aAs type V (254 base pairs) confirming the presence of this type in 299 
the tissues tested (43.5% of liver, 19.6% of spleen and 36.9% of kidney samples). From the 300 
29 positive fish, 16 (55.2%) had survived the challenge trial and 13 (44.8 %) were moribund 301 
fish (Table 4). There were no discernible differences in the number of positive samples from 302 
fish challenged with either of the two aAs vapA type V stains. All the individuals challenged 303 
with Vibrionaceae isolates were negative. 304 
As vapA qPCR 305 
In total, 13 of the 28 fish (or 46.4 %) that were positive by a As vapA qPCR were moribund 306 
fish and 15 (or 53.6 %) were survivors (subclinical) during the challenge trial. Of the 28 positive 307 
fish, 12 (42.8 %) had a high bacterial load with a Crossing point (Cp) value between 18 and 308 
24. The liver (16/41; 39.0 %) and kidney (15/41; 36.6 %) samples had higher bacteria loads 309 
that the spleen (10/41; 24.4 %). There were no differences between bacteria load for 310 
individuals challenged with either of the two aAs vapA type V stains. All control samples tested 311 
(30) were negative. 312 
Discussion  313 
Bacterial disease outbreaks have impeded advancement of the ballan wrasse industry in 314 
Scotland. In the present work one of the two aAs vapA type V stains was more virulent during 315 
the bath challenge experiment developed herein. Infected fish displayed clinical signs, 316 
however the disease impacts were more remarkable upon post-mortem examination. Internal 317 
lesions in challenged fish were severe including multi focal granulomas in the liver, 318 
hepatomegaly and splenomegaly. Eosinophilic granular cells and macrophages were the main 319 
leukocytes involved in inflammatory response following histological examination. In contrast, 320 
bath challenge of ballan wrasse with V. anguillarum, Alliv. salmonicida and Phot. indicum, did 321 
not result in notable mortalities, despite challenging under similar conditions as aAs isolates.  322 
The significantly higher mortality rates following bath challenge with aAs compared to all other 323 
bacterial species tested in this study, indicates that juvenile ballan wrasse are more 324 
susceptible to this bacterium. Both aAs strains used in the experimental infection were vapA 325 
type V, which is a predominant vapA type (in addition to VI) to which ballan wrasse have been 326 
reported susceptible to (Gulla et al., 2016a; Papadopoulou et al., 2020). Fish were exposed 327 
to high doses of bacterial broth cultures (2.84 x 107 CFU / mL for strain TW 4 / 14 and 1.93 x 328 
107 CFU / mL and 2.04 x 108 CFU / mL for strain TW 3 / 14), as required for a successful bath 329 
challenge model. The cumulative mortalities were higher for strain TW 4 / 14 than TW 3 / 14 330 
at similar doses, which suggested that the former strain was more virulent than the latter even 331 
though they belong to the same vapA type (V). This is in agreement with our previous findings 332 
following an i.p. injection challenge trial (Ramirez Paredez et al., 2020). In addition, in this 333 
study, no histological differences, or notable changes in aAs prevalence, were noted between 334 
fish samples collected from fish challenged with the different strains. Furthermore, pure 335 
cultures of the bacterium (aAs) grew on TSA plates from kidney swabs taken from 10 % of 336 
moribund fish  from each tank and no control fish died throughout the experiment, confirming 337 
that aAs was causing the disease in infected individuals. In a previous study, aAs (vapA type 338 
V) induced 75 – 89 % mortalities after i.p. injection in 50 g ballan wrasse and 51 % mortality 339 
with a cohabitation infection challenge (Biering et al., 2016). In the same study aAs (vapA type 340 
VI) was notably less virulent by cohabitation challenge (8 %) while i.p. caused 70 – 85 % 341 
mortality. This higher mortality rate is, however, not surprising as i.p. administration of the 342 
pathogen bypasses the mucosal tissue barriers (e.g. skin, gill and gut) and results in higher 343 
mortalities in fish (Embregts & Forlenza, 2016; Adams, 2019).  344 
Gross pathology was similar in fish from all tanks challenged with aAs strains. Exophthalmia 345 
and eroded fins were two of the most predominant clinical signs in conjunction with lethargy, 346 
loss of equilibrium and inappetence. Externally the response of infected ballan wrasse to aAs 347 
following the bath challenge was less severe in comparison with other fish species like 348 
salmonids in which large furuncules on the skin of infected fish are often observed (Austin & 349 
Austin, 2016). Similarly, the external clinical disease appears less severe that that reported 350 
for other  non - salmonids species where the clinical picture includes ulceration in cod 351 
(Magnadottir et al., 2002), black rock fish (Sebastes schlegeli) (Han et al., 2011), sailfin 352 
sandfish (Artoscopus japonicas) (Wada et al., 2010) and granulomatous dermatitis in turbot 353 
(Farto et al., 2011; Coscelli, Bermúdez, Losada, et al., 2014; Coscelli, Bermúdez, Silva, et al., 354 
2014). Internally, however, the pathological impacts of aAs are clear whereby the liver, spleen 355 
and hearts of infected ballan wrasse were the most affected organs in this study. 356 
Hepatomegaly and splenomegaly was noted macroscopically while internally white nodular 357 
lesions were present in these organs.  358 
In a recent report of viral haemorrhagic septicaemia (VHS) in the Shetland Islands in Scotland, 359 
the presence of EGCs in the pancreas of wrasse species, including ballan wrasse, was 360 
described by Munro et al. (2015). Reite and Evensen (2006), in their review on fish 361 
inflammatory cells, also reported that the eosinophilic component of leukocytes were dominant 362 
in the Labridae family. The eosinophilic granular cells observed in the current study were 363 
associated with a granulomatous response, surrounding the bacteria in the liver creating the 364 
centre of the granulomas. The heart and kidneys were found to be the least affected, despite 365 
aAs being present in a considerable proportion of kidney samples tested by PCR/qPCR, thus 366 
perhaps indicating rapid clearance of the bacterium. Specifically, no changes were noted in 367 
kidneys of control and infected individuals although EGCs were seen in both groups. Even 368 
though the role of EGCs is not completely known in ballan wrasse, their function appears to 369 
match mast cells in mammals which release chemical mediators and phagocytose foreign 370 
particles (Reite, 1998). 371 
The granulomatous response was also characterised by macrophage infiltration observed in 372 
the liver, pancreas, and spleen of fish infected with aAs. Epithelioid macrophages created the 373 
outer layers of the granuloma wall, separating the bacteria from the healthy hepatic cells. 374 
Macrophage infiltration was also observed, replacing the normal splenic tissue, which caused 375 
congestion and swelling of the organ. The livers of infected ballan wrasse also showed 376 
increased vacuolation similar to the aAs infection in walking catfish (Clarias batrachus) 377 
(Menanteau-Ledouble et al., 2016). Necrosis in the kidney, spleen and gut were previously 378 
reported in salmonids during aAs exposure with an increased number of infiltrating 379 
macrophages (Menanteau-Ledouble et al., 2016), however such changes were not observed 380 
in the kidney or gut in the present study. 381 
Bacterial presence in the tissues of infected and control fish was confirmed with a series of 382 
molecular assays. Initially a broad range PCR (16S) was used to determine the presence of 383 
bacteria DNA in the samples. Aeromonas salmonicida are categorised in 23 known A-layer 384 
types and for this work vapA type V was detected using a vapA type V-specific assay 385 
(Papadopoulou, 2019). Bacterial loads were also assessed with the As species specific qPCR 386 
designed on the A-layer of the virulent array protein gene (Gulla et al., 2016b). In total, 59 out 387 
of 64 fish (103 out of 179 tissue samples) had bacterial DNA in their tissues including 8 control 388 
fish. However, none of the control fish showed a positive result when screened with the aAs 389 
specific PCRs (vapA and type V) and the absence of mortalities in the control replicates during 390 
the trial confirmed the lack of potentially confounding bacterial pathogens. In total 21 fish were 391 
positive for the presence of As DNA (vapA PCR) while 26 were positive for vapA type V 392 
specific PCR.  The higher number of positive fish detected with the vapA type V specific PCR 393 
may suggest a greater sensitivity of the assay for detecting aAs (type V) DNA in the samples 394 
in comparison with vapA PCR. Lastly, the aAs loads were measured in the same samples by 395 
qPCR. From 64 fish samples 28 were positive, making this assay the most sensitive in 396 
comparison with the other two PCRs (vapA and vapA type V specific). This was expected as 397 
the qPCR assay is able to detect as little as 7-8 As genomes (Gulla et al., 2016b). The varying 398 
bacterial loads seen across different organs and samples most likely indicate different stages 399 
of infection following the experimental challenge trial. This concurs with (Gulla et al., 2016b) 400 
who also showed that qPCR did not always produce positive results when expected due to 401 
variable stages of infection or when the DNA concentration of the bacteria is too low.  402 
In this study, the Scottish V. anguillarum isolate (TW260/16) caused the second highest 403 
cumulative mortality between the different bacteria species tested (4 %). Interestingly, no 404 
mortalities were seen from the Norwegian V. anguillarum isolate in contrast to a previous trial 405 
in Norway where higher mortalities (10 – 15 %) were reported in a bath challenge with two 406 
strains of V. anguillarum (Biering et al., 2016). Variations in the genome of the bacterium and 407 
country of origin of the fish may explain these results (Busschaert et al., 2015; Castillo et al., 408 
2017). The Norwegian isolate included in this study was expected to be more virulent, as 409 
bacterial isolates are usually more virulent when coming into contact with hosts from different 410 
geographical locations due to the lack of adaptation to the host species (Anderson & Siwicki, 411 
1994). Alliv. salmonicida and Phot. indicum were less virulent to the fish resulting in 1 % and 412 
0 % mortalities, respectively. Alliv. salmonicida is known to cause cold – water vibriosis in 413 
Atlantic salmon and rainbow trout at temperatures between 3 and 10 °C (Egidius et al., 1981) 414 
but it does not cause clinical disease at temperatures higher than 14 °C (Colquhoun et al., 415 
2002). This may explain the very low percentage mortality incurred to fish in the present trial 416 
despite the fact that these isolates had been isolated from the host at similar ‘higher’ 417 
temperatures (15 °C). It could also indicate that the isolate in these circumstances acted as 418 
an opportunistic pathogen to already immunocompromised hosts. However, it should be noted 419 
that the lack of mortalities during the infection with Phot. indicum could also be related to low 420 
numbers of viable bacteria in the suspension used for challenge (2.66 x 105 and 3.12 x 105 421 
CFU / mL) than the target dose 108 CFU / mL. This is likely to be due to harvesting of the 422 
bacteria towards the end of the exponential phase and perhaps including bacterial cells 423 
harvested during the decline (death) phase. We previously noted at least 50 % mortalities in 424 
juvenile ballan wrasse when infected by i.p. with Phot. indicum (Ramirez Paredez et al., 2020). 425 
Growth curve testing and shorter incubation times (< 24 h) may help addressing the problem 426 
we encountered in this study to enable reassessment of the pathogenicity of the isolate on 427 
juvenile ballan wrasse by bath inoculation.  428 
In conclusion, we successfully developed a bath challenge model for aAs vapA type V in 429 
farmed ballan wrasse for the first time which can now be used as a model for vaccine efficacy 430 
testing as it is not invasive and simulates natural bacterial portals of entry in contrast to i.p. 431 
injection. The disease caused more severe internal than external pathology in comparison 432 
with other species (salmonids and non – salmonids) infected with the same bacterial species. 433 
Gross external and internal pathology, alongside histological changes of infected ballan 434 
wrasse tissues with the bacterium aAs were described following experimental aAs bath 435 
challenge conditions. Microscopically, granulomatous hepatitis with EGCs surrounding 436 
bacterial colonies and endocarditis along with splenic histiocytosis in moribund and surviving 437 
fish were observed. This bath challenge model is now being applied in immunocompetence 438 
and vaccine efficacy studies for juvenile ballan wrasse. 439 
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  646 
Table 1. Bacterial isolates used in this study. All bacterial isolates recovered from diseased 647 
ballan wrasse (Labrus bergylta) in Scotland with the exception of a single isolate recovered 648 
from the species in Norway.  649 
 650 
Bacterial species  Isolate ID  Year of 
isolation  
Aeromonas salmonicida (vapA type V) TW 3 / 14 2014 
Aeromonas salmonicida (vapA type V) TW 4 / 14 2014 
Vibrio anguillarum TW 260 / 16 2016 
Vibrio anguillarum 12-50-2075 F383-1* < 2014 
Aliivibrio salmonicida   TW 189 / 16 2016 
Aliivibrio salmonicida TW 322 / 16 2016 
Photobacterium indicum   TW 138 / 16 2016 
Photobacterium indicum   TW 181 / 16 2016 
(*) Norwegian isolate 651 
 652 
  653 
Table 2. Cumulative mortalities of ballan wrasse (Labrus bergylta) infected with atypical 654 
Aeromonas salmonicida, Vibrio anguillarum, Allivibrio salmonicida and Photobacterium 655 
indicum. No mortalities were recorded for control groups.  656 




salmonicida vapA type V 



























(*) No duplicate tanks 657 









Table 3. Primers used for amplification of broad bacterial DNA, Aeromonas salmonicida and 667 
atypical Aeromonas salmonicida vapA type V specific with conventional PCR and primers for 668 
bacterial load with qPCR. 669 








F341:  CCTACGGGNGGCWGCAG 
R805:  GACTACHVGGGTATCTAATCC 
54.0 485 
(Herlemann et 
al., 2011)  
vapA partial 
 
F2:  CTGGACTTCTCCACTGCTCA 
R3:  ACGTTGGTAATCGCGAAATC 
53.0 625 










et al., 2020) 
vapA 





















Table 4. Ballan wrasse (Labrus bergylta) samples (liver, kidney and spleen) from moribund, 685 
survivor and control fish screened with a PCR for bacterial presence (16S), atypical 686 
Aeromonas salmonidisa (aAs) specific (vapA type V) and aAs type specific PCR (vapA type 687 
V specific) as well as a qPCR for aAs loads. 688 
 689 
Tissue / Fish status Total 16S vapA V specific qPCR 
Liver 63 39 13 20 16 
Spleen 53 23 7 9 10 
Kidney 63 41 10 17 15 
Tissues samples 179 103 30 46 41 
      
Moribund fish 20 12 11 13 13 
Survivors 34* 35 10 16 15 
Control fish 10 8 0 0 0 
Total number of fish 64 55 21 29 28 
(*) includes 19 individuals challenged with TW 3 / 14 (dose 107) but mortalities did not reach 690 
a plateau at termination.  691 
 692 
  693 
Figure 1. Cumulative mortalities of ballan wrasse (Labrus bergylta) bath challenged with 694 
atypical Aeromonas salmonicida vapA type V strain TW 3 / 14 (interrupted line) and TW 4 / 14 695 
(continuous line).  696 
Figure 2. Gross pathology and Internal gross pathology of infected ballan wrasse (Labrus 697 
bergylta) with atypical Aeromonas salmonicida following bath challenge. A) Bilateral 698 
exophthalmia and haemorrhage between the eyes, B) eroded pectoral fins and petechiae on 699 
the body (arrow head).C) Dark red intestine (circle) D) hepatomegaly and white nodular 700 
lesions in the liver (arrow heads). 701 
 702 
Figure 3.  Ballan wrasse liver infected with atypical Aeromonas salmonicida. A) Arrow heads 703 
delineating three large granulomas composed of a thick wall of epithelioid macrophages (black 704 
arrows) encircling degenerate and non-degenerate eosinophilic granular cells which 705 
themselves surround large bacterial colonies B) The region highlighted in a box in A). Detail 706 
of wall and centre of granuloma. Degenerate eosinophilic granular cells (E) surrounding 707 
atypical Aeromonas salmonicida colonies (B), delineated by a dense rim of epithelioid 708 
macrophages. Degenerate hepatocytes are present at the periphery (arrow heads) along with 709 
small numbers of lymphocytes.  C) Multiple poorly organised hepatic granulomas centred on 710 
bacterial colonies. Note the moderate distension of hepatic sinusoids throughout the 711 
parenchyma. D) Very early site of infection showing bacterial colonies surrounded by a fine 712 
rim of karyorrhectic cellular debris (arrow heads), admixed with occasional macrophages, 713 
EGCs and lymphocytes. Scale bar 100 μm for A) and C) and 20 μm for B) and D). 714 
Figure 4. Hematoxylin and Eosin stained slides of ballan wrasse (Labrus bergylta) pancreases 715 
and peritoneum fixed in 10% neutral buffered formalin from atypical Aeromonas salmonicida 716 
bath challenge. (A) Healthy pancreas of ballan wrasse (B) Healthy pancreas of ballan wrasse 717 
with adjacent fat cells (+), exocrine pancreatic cells, mild infiltrate of eosinophilic granular cells 718 
(arrow head). (C) Pancreas of ballan wrasse with peritonitis in a fish infected with atypical 719 
Aeromonas salmonicida. (D) Pancreas with infiltration of phagocytic macrophages and 720 
eosinophilic granular cells replacing the peripancreatic adipose cells (arrow head). Scale bar 721 
50 μm for A) and C) and 20 μm for B) and D). 722 
Figure 5. Ballan wrasse (Labrus bergylta) control and infected spleens with atypical 723 
Aeromonas salmonicida stained with H&E. (A) Healthy spleen of a ballan wrasse with normal 724 
splenic haematopoietic tissue and ellipsoids (black arrow). (B) Healthy spleen of a ballan 725 
wrasse with visible erythrocytes and haematopoietic tissue. (C) Spleen of a ballan wrasse 726 
infected with atypical Aeromonas salmonicida with infiltration of macrophages replacing the 727 
normal splenic tissue. (D) Spleen of a ballan wrasse infected with atypical Aeromonas 728 
salmonicida with mild congestion and macrophage infiltration (arrow head). Scale bar 20 μm 729 
for A) and C) and 10 μm for B) and D). 730 
Figure 6. Ballan wrasse (Labrus bergylta) livers infected with atypical Aeromonas 731 
salmonicida.  A and B Gram-negative bacilli-shaped bacteria (arrow head) inside granuloma 732 
H&E (scale bar 20 and 10 μm, respectively). B) The region highlighted in a box in A), arrow 733 
heads indicate bacilli-shaped bacteria. C and D Gram-negative bacilli-shaped bacteria (arrow 734 
head) inside granuloma. D) The region highlighted in a box in C), arrow heads indicate Gram-735 
negative bacilli-shaped bacteria (scale bar 20 and 10 μm, respectively). 736 
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